Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Nat Med
    March 2026
  1. BOLSEWIG K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, et al
    A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.
    Nat Med. 2026;32:1073-1084.
    >> Share

    September 2025
  2. ALI M, Erabadda B, Chen Y, Xu Y, et al
    Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
    Nat Med. 2025 Sep 2. doi: 10.1038/s41591-025-03970.
    >> Share

    August 2025
  3. SHVETCOV A, Johnson ECB, Winchester LM, Walker KA, et al
    APOE epsilon4 carriers share immune-related proteomic changes across neurodegenerative diseases.
    Nat Med. 2025;31:2590-2601.
    >> Share

  4. IMAM F, Saloner R, Vogel JW, Krish V, et al
    The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.
    Nat Med. 2025;31:2556-2566.
    >> Share

    July 2025
  5. ALI M, Erabadda B, Chen Y, Xu Y, et al
    Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
    Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833.
    >> Share

    June 2025
  6. HEALEY N
    Stem cell therapies advance in Parkinson's disease and beyond.
    Nat Med. 2025 Jun 4. doi: 10.1038/d41591-025-00036.
    >> Share

    April 2025
  7. O'LEARY K
    Progress with stem cell therapy in Parkinson's disease.
    Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00029.
    >> Share

    February 2025
  8. SOTO C, Mollenhauer B, Hansson O, Kang UJ, et al
    Toward a biological definition of neuronal and glial synucleinopathies.
    Nat Med. 2025;31:396-408.
    >> Share

    January 2025
  9. MOREAU C, Odou P, Labreuche J, Demailly A, et al
    Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trial.
    Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03428.
    >> Share

  10. CASTRO-ALDRETE L, Huc M, Domingos J, Vaudano E, et al
    Using a sex- and gender-informed lens to enhance care in Parkinson's disease.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03363.
    >> Share

    October 2024
  11. PAGANO G, Monnet A, Reyes A, Ribba B, et al
    Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.
    Nat Med. 2024 Oct 8. doi: 10.1038/s41591-024-03270.
    >> Share

    September 2024
  12. EIJSVOGEL P, Misra P, Concha-Marambio L, Boyd JD, et al
    Target engagement and immunogenicity of an active immunotherapeutic targeting pathological alpha-synuclein: a phase 1 placebo-controlled trial.
    Nat Med. 2024;30:2631-2640.
    >> Share

    August 2024
  13. OEHRN CR, Cernera S, Hammer LH, Shcherbakova M, et al
    Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson's disease: a blinded randomized feasibility trial.
    Nat Med. 2024 Aug 19. doi: 10.1038/s41591-024-03196.
    >> Share

    April 2024
  14. MULIYIL S
    Repurposing a diabetes drug to treat Parkinson's disease.
    Nat Med. 2024 Apr 20. doi: 10.1038/d41591-024-00026.
    >> Share

  15. PAGANO G, Taylor KI, Anzures Cabrera J, Simuni T, et al
    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
    Nat Med. 2024;30:1096-1103.
    >> Share

    January 2024

  16. Wearable robot helps man with Parkinson's disease to walk.
    Nat Med. 2024 Jan 15. doi: 10.1038/s41591-023-02756.
    >> Share

  17. KIM J, Porciuncula F, Yang HD, Wendel N, et al
    Soft robotic apparel to avert freezing of gait in Parkinson's disease.
    Nat Med. 2024 Jan 5. doi: 10.1038/s41591-023-02731.
    >> Share

    November 2023
  18. MIZRAHI-KLIGER A, Ganguly K
    Spinal stimulation for unfreezing gait in Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02604.
    >> Share

  19. MILEKOVIC T, Moraud EM, Macellari N, Moerman C, et al
    A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02584.
    >> Share

    August 2023
  20. QUADALTI C, Palmqvist S, Hall S, Rossi M, et al
    Clinical effects of Lewy body pathology in cognitively impaired individuals.
    Nat Med. 2023;29:1964-1970.
    >> Share

    July 2023
  21. SCHALKAMP AK, Peall KJ, Harrison NA, Sandor C, et al
    Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosis.
    Nat Med. 2023 Jul 3. doi: 10.1038/s41591-023-02440.
    >> Share

    June 2023
  22. OKUZUMI A, Hatano T, Matsumoto G, Nojiri S, et al
    Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies.
    Nat Med. 2023;29:1448-1455.
    >> Share

    April 2023
  23. O'LEARY K
    Biomarker study a game-changer for Parkinson's disease.
    Nat Med. 2023 Apr 27. doi: 10.1038/d41591-023-00039.
    >> Share

    March 2023
  24. O'LEARY K
    Ultrasound-based treatment for Parkinson's disease.
    Nat Med. 2023 Mar 6. doi: 10.1038/d41591-023-00026.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016